~~<i id='0B50B5BAA6'><strike id='0B50B5BAA6'><tt id='0B50B5BAA6'><pre id='0B50B5BAA6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

author：comprehensive 2025-09-30 18:00:03 - browse：57

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： The new shift in health care is toward less care

entertainment

focus

Wikipedia

hotspot

explore

Wikipedia

ApersoncoolingoffinPhoenixduringlastJuly'sheatwave.BrandonBell/GettyImagesTheworld’shottestsummeronr

WSS

UCSF medical school apologizes for unethical prisoner experiments

Abortion clinic in Cancun will cater to Americans

Will General Catalyst be the first of many hospital takeovers?

Nick Jonas talks about managing diabetes along with his career

The new shift in health care is toward less care

European regulators recommend Amylyx's ALS drug be rejected

hotspot

hotspot

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Abortion clinic in Cancun will cater to Americans

ChatGPT in medicine: STAT answers readers' burning questions

UCSF medical school apologizes for unethical prisoner experiments

Tori Bowie and the unacceptable rates of Black maternal death

What's changing in Medicare's open enrollment this year?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Free speech concerns arise in wake of journal editor Eisen's firing

Apple is now the first public company to be valued at $3 trillion

Excited delirium, Elijah McClain, and emergency physicians

focus

10 million people disenrolled from Medicaid over past six months

Sanofi CEO defends move to abandon profit guidance, boost research

How should state employee insurance handle Wegovy?

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

What's changing in Medicare's open enrollment this year?

European regulators consider appeal over Amylyx ALS drug

Wikipedia

hotspot

explore

Wikipedia